Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Pancreatitis of biliary origin: Optimal timiNg CHOlecystectomy (PONCHO) trial
ISRCTN ISRCTN72764151
ClinicalTrials.gov identifier
Public title Pancreatitis of biliary origin: Optimal timiNg CHOlecystectomy (PONCHO) trial
Scientific title Pancreatitis of biliary origin: Optimal timiNg CHOlecystectomy (PONCHO) trial. A randomised controlled multicentre trial of the Dutch Pancreatitis Study Group.
Acronym PONCHO
Serial number at source N/A
Study hypothesis We hypothesise that early timing of laparoscopic cholecystectomy (ELC) would prevent recurrent biliary pancreatitis or other complications of gall-stone disease in patients with mild biliary pancreatitis.

Study conducted in accordance with the principles of the Declaration of Helsinki.
Lay summary
Ethics approval Approved by the Arnhem-Nijmegen Regional Committee on Research Involving Human Subjects (Commissie Mensgebonden Onderzoek [CMO] regio Arnhem-Nijmegen).
The study protocol will also be approved by all participating hospitals.
Study design Multicentre randomised controlled parallel group superiority trial
Countries of recruitment Netherlands
Disease/condition/study domain Mild biliary pancreatitis
Participants - inclusion criteria 1. Age 18 years or older
2. Mild (non-severe) biliary pancreatitis, without sterile pancreatic necrosis and/or peripancreatic collections.
3. Written and oral informed consent (obtained prior to randomisation)
Participants - exclusion criteria 1. Patients <18 years
2. Patients >75 years with ASA III
3. ASA IV and V patients
4. Patients with history of alcohol abuse or chronic pancreatitis
5. Mild pancreatitis with sterile pancreatic necrosis and/or peripancreatic collections
6. Severe pancreatitis: persistent (>48hrs) organ failure or necrotizing pancreatitis
Anticipated start date 01/01/2011
Anticipated end date 01/07/2013
Status of trial Ongoing
Patient information material Not available in web format, please use contact details below to request a patient information sheet
Target number of participants 266
Interventions 1. Intervention group:
Laparoscopic cholecystectomy within 72 hours after randomisation (ELC).
2. Control group:
Laparoscopic cholecystectomy 25-30 days after randomization (ILC).

Patients are randomised when the treating physician feels the patient can be discharged within 1-2 days and all signs of acute disease have resolved.
Primary outcome measure(s) Composite endpoint: Unplanned re-admission for biliary events (recurrent biliary pancreatitis, acute cholecystitis, choledocholithiasis mandating ERCP, biliary colics)
Secondary outcome measure(s) 1. Individual components of the primary endpoint
2. Number of biliary colics after randomisation
3. Length of hospital stay
4. Operation difficulty (VAS)
5. Duration
6. Complications and conversion rate of laparoscopic cholecystectomy
7. Costs per primary endpoint avoided
8. Quality adjusted life year (QALY) gained
9. Mortality
10. Patient satisfaction
Sources of funding Radboud University Nijmegen Medical Centre (Netherlands) - internal funding
Trial website http://www.pancreatitis.nl
Publications
Contact name Prof  H G  Gooszen
  Address Dutch Pancreatitis Study Group
Department of Surgery
Radboud University Nijmegen Medical Centre
HP 690
PO Box 9101
  City/town Nijmegen
  Zip/Postcode 6500HB
  Country Netherlands
  Tel +31 (0)243 655764 / 66458
  Fax +31 (0)243 613834
  Email H.Gooszen@ok.umcn.nl
Sponsor Radboud University Nijmegen Medical Centre (Netherlands)
  Address Dutch Pancreatitis Study Group
Department of Surgery
HP 557
PO Box 9101
Mobile: +31 (0)617401029
  City/town Nijmegen
  Zip/Postcode 6500HB
  Country Netherlands
  Sponsor website: http://www.pancreatitis.nl
Date applied 26/05/2010
Last edited 29/06/2010
Date ISRCTN assigned 29/06/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central